DYNASTY CONSTRUCTION ENGINEERING PTE. LTD.
UEN: 200512938D
DYNASTY CONSTRUCTION ENGINEERING PTE. LTD.(200512938D) is a Singapore business with registered business address at 3 SOON LEE STREET, 1-35, PIONEER JUNCTION, Singapore 627606. They specialise in the area of METAL PRODUCT SERVICES N.E.C. and BUILDING CONSTRUCTION N.E.C..
| Company Name | DYNASTY CONSTRUCTION ENGINEERING PTE. LTD. |
| Unique Entity Number | 200512938D |
| Entity Type | Local Company |
| Entity Status | Live Company |
| Incorporate Day | 16 September 2005 |
| Address |
3 SOON LEE STREET #1-35 PIONEER JUNCTION Singapore 627606 |
| Products / Services |
METAL PRODUCT SERVICES N.E.C. BUILDING CONSTRUCTION N.E.C. |
| Number of Officers | 5 |
| Paid Up Capital | SGD 100000 |
Breaking! Business News
Congenica and Camtech Diagnostics agree strategic partnership to support genomic analysis platform expansion in AsiaCongenica and Camtech Diagnostics agree strategic partnership to support genomic analysis platform e...
Read More
Giving Back, Changing Lives: inCruises Partners with Mercy Ships to Transform Lives in AfricaGiving Back, Changing Lives: inCruises Partners with Mercy Ships to Transform Lives in AfricaGlobeN...
Read More
Immunocore presents phase 3 data comparing tebentafusp with investigator’s choice in the clinical trial plenary session at the American Association for Cancer Research 2021 Annual MeetingImmunocore presents phase 3 data comparing tebentafusp with investigator’s choice in the clinical ...
Read More
Global Smart Commodity Group to host Aloe Contracts on Salus PlatformGlobal Smart Commodity Group to host Aloe Contracts on Salus PlatformGlobeNewswireApril 12, 2021CHIC...
Read More
IIA Signs MOU with Vietnam’s Ministry of FinanceIIA Signs MOU with Vietnam’s Ministry of FinanceCollaboration focuses on furthering the mission of...
Read More
NMPA Approves Toripalimab in Patients with Locally Advanced or Metastatic Urothelial Carcinoma who Failed Platinum-Containing Chemotherapy or Progressed within 12 Months of Neoadjuvant or Adjuvant Platinum-Containing ChemotherapyNMPA Approves Toripalimab in Patients with Locally Advanced or Metastatic Urothelial Carcinoma who F...
Read More
Health Canada Issues Resverlogix Authorization to Begin Immediate Clinical Studies of Apabetalone for COVID-19Health Canada Issues Resverlogix Authorization to Begin Immediate Clinical Studies of Apabetalone fo...
Read More
Colliers releases first Global Impact ReportColliers releases first Global Impact ReportDevelopment of full impact position and comprehensive st...
Read More